半乳糖凝集素1(GAL1)重組蛋白
Recombinant Galectin 1 (GAL1)
LGALS1; GBP; HLBP14; Galaptin; Lectin,Galactoside-Binding Soluble 1; 14 kDa laminin-binding protein; Lactose-binding lectin 1; Putative MAPK-activating protein PM12; S-Lac lectin
- 編號(hào)RPA321Bo01
- 物種Bos taurus; Bovine (Cattle，牛) 相同的名稱，不同的物種。
- 來(lái)源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位細(xì)胞外基質(zhì)
- 預(yù)測(cè)分子量16.0kDa
- 實(shí)際分子量15kDa(差異分析請(qǐng)參閱說(shuō)明書)
- 片段與標(biāo)簽Met1~Glu135 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)6.2
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見(jiàn)活性蛋白。 - 下載 英文說(shuō)明書 中文說(shuō)明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 1152 ¥ 2880 ¥ 5760 ¥ 17280 ¥ 43200
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure. Gene Sequencing (Extract)
-
SDS-PAGE圖
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月，-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Bos taurus; Bovine (Cattle，牛) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| APA321Bo01 | 半乳糖凝集素1(GAL1)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA321Bo01 | 半乳糖凝集素1(GAL1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA321Bo01 | 半乳糖凝集素1(GAL1)多克隆抗體 | WB; IHC; ICC; IP; FCM |
| LAA321Bo81 | 半乳糖凝集素1(GAL1)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| LAA321Bo71 | 半乳糖凝集素1(GAL1)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAA321Bo24 | 半乳糖凝集素1(GAL1)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA321Bo22 | 半乳糖凝集素1(GAL1)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA321Bo23 | 半乳糖凝集素1(GAL1)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA321Bo21 | 半乳糖凝集素1(GAL1)單克隆抗體 | WB; IHC; ICC; IP. |
| FAA321Bo08 | 抗半乳糖凝集素1(GAL1)單克隆抗體 | Flow cytometry. |
| FAA321Bo06 | 抗半乳糖凝集素1(GAL1)單克隆抗體 | Flow cytometry. |
| FAA321Bo04 | 抗半乳糖凝集素1(GAL1)單克隆抗體 | Flow cytometry. |
| FAA321Bo02 | 抗半乳糖凝集素1(GAL1)單克隆抗體 | Flow cytometry. |
| SEA321Bo | 半乳糖凝集素1(GAL1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA321Bo | 半乳糖凝集素1(GAL1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSA321Bo01 | 半乳糖凝集素1(GAL1)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| International Journal of Oncology | Galectin-1-mediated cell adhesion, invasion and cell death in human anaplastic large cell lymphoma: Regulatory roles of cell surface glycans [Pubmed:24589677] |
| Clinica Chimica Acta | Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population [Pubmed:25578395] |
| Journal of Perinatal Medicine | Cord blood galectin-1 and-3 concentrations in term pregnancies with normal restricted and increased fetal growth [PubMed: 24717333] |
| Biomaterials | Noninvasive small-animal imaging of galectin-1 upregulation for predicting tumor resistance to radiotherapy [Pubmed:29272764] |
| Advances in Experimental?Medicine?and?Biology | Molecules of Damage-Associated Patterns in Bronchoalveolar Lavage Fluid and Serum in Chronic Obstructive Pulmonary Disease [Pubmed:29429028] |
| RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY | Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis [Pubmed: 31678459] |
| Eur J Nucl Med Mol Imaging | Galectin expression detected by 68Ga-galectracer PET as a predictive biomarker of radiotherapy resistance [Pubmed:35106644] |
| Medicine | Regulatory T cells, damage-associated molecular patterns, and myeloid-derived suppressor cells in bronchoalveolar lavage fluid interlinked with chronic obstructive?… [Pubmed:35687771] |
| In Vitro Bovine Embryo Production Using Medium's Supplemented with Recombinant Human Galectin-1 Buffered [] |
留言咨詢
